SPX Reports First Quarter 2021 Results
May 06, 2021 16:02 ET
|
SPX Corporation
Q1 2021 GAAP EPS of $0.60; Q1 2021 Adjusted EPS* of $0.68;Updating 2021 Full-Year Guidance for Sealite Acquisition; Anticipate Full-Year Adjusted EPS* in a Range of $3.06-$3.26 CHARLOTTE, N.C., May ...
Sprouts Farmers Market, Inc. Reports First Quarter 2021 Results
May 06, 2021 16:02 ET
|
Sprouts Farmers Market
PHOENIX, May 06, 2021 (GLOBE NEWSWIRE) -- Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week first quarter ended April 4, 2021. First Quarter Highlights: Net sales...
iTeos publiera ses résultats financiers pour le premier trimestre 2021 et fournira une mise à jour institutionnelle le 13 mai 2021
May 06, 2021 16:01 ET
|
iTeos Therapeutics Inc.
CAMBRIDGE, Mass. et GOSSELIES, Belgique, 06 mai 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq : ITOS), une société biopharmaceutique au stade clinique pionnière dans la découverte et le...
Ross Stores Announces First Quarter 2021 Earnings Release and Conference Call
May 06, 2021 16:01 ET
|
Ross Stores, Inc.
Dublin, California, May 06, 2021 (GLOBE NEWSWIRE) -- Dublin, California -- Ross Stores, Inc. (NASDAQ: ROST) plans to release its first quarter 2021 earnings results on May 20, 2021 at...
Aterian Reports First Quarter 2021 Results
May 06, 2021 16:01 ET
|
Aterian, Inc.
Quarterly Net Revenue Grew 88% Year-Over-Year to $48.1 Million Announces Acquisition of Squatty Potty, a Leading Health & Wellness Brand Announces Closing of Previously Disclosed Photo Paper...
Coherus BioSciences Reports First Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
May 06, 2021 16:01 ET
|
Coherus BioSciences, Inc.
– Junshi Biosciences transaction is followed by rapid toripalimab progress including initiation of first BLA submission to the U.S. FDA, positive interim analysis in pivotal esophageal cancer trial,...
Travere Therapeutics Reports First Quarter 2021 Financial Results
May 06, 2021 16:01 ET
|
Travere Therapeutics, Inc.
Pivotal PROTECT Study of sparsentan in IgA nephropathy nears completion of patient enrollment; topline proteinuria data expected 3Q21 Net product sales of $47.4 million for the first quarter of...
Natus Medical Announces First Quarter 2021 Financial Results
May 06, 2021 16:01 ET
|
Natus Medical Incorporated
Q1-2021 Key ResultsRevenue (millions)$114.9 • Revenue increased 5% compared to Q1 2020 and in-line with Q1 2019GAAP EPS$0.07 • Generated $24.7 million in operating cash flowNon-GAAP EPS$0.16 • GAAP...
Iovance Biotherapeutics Reports First Quarter 2021 Financial Results and Corporate Updates
May 06, 2021 16:01 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies...
Galapagos refocuses pipeline and rightsizes operations
May 06, 2021 16:01 ET
|
Galapagos NV
First three months 2021 financial results: Group revenues and other income of €124.2 millionOperating loss of €50.8 millionNet profit of €9.4 millionCash and current financial investments of...
- September 25, 2024 22:22 ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Endava
- September 25, 2024 22:04 ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PDD Holdings f/k/a Pinduoduo